dr. pavlick on the safety profile of cemiplimab in cscc
Published 4 years ago • 250 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:38
dr. pavlick on longer follow-up data with cemiplimab in cscc
-
1:54
dr. pavlick on immunotherapy clinical trials in basal and squamous cell carcinomas
-
0:59
dr. pavlick on the columbus trial in metastatic melanoma
-
1:37
dr. atlas on the promise of up-front cemiplimab in locally advanced cscc
-
0:53
dr. pavlick on adjuvant immunotherapy in high-risk melanoma
-
10:44
dr c m wavikar| i talk | panoptix (approach in presbyopia)
-
5:08
axumin vs pylarify psma pet/ct
-
3:10
helping you understand cutaneous squamous cell carcinoma
-
0:37
dr. rischin on the fda approval of cemiplimab for cscc
-
1:23
dr. olszanski on patient selection for cemiplimab treatment in cscc
-
1:14
dr. pavlick on importance of immunotherapy in metastatic melanoma
-
6:22
cscc: the role of cemiplimab in clinical data and clinical practice
-
7:01
cemiplimab phase i trial
-
1:04
dr. atlas on the rationale for cemiplimab in locally advanced cscc
-
7:22
advanced/metastatic cscc treatment options
-
1:18
neoadjuvant cemiplimab in patients with stage ii-iv cutaneous squamous cell carcinoma
-
4:06
next steps in the treatment of cscc
-
1:07
cemiplimab mode of action
-
4:51
advanced cscc: the new systemic therapy
-
0:47
dr. stratigos the rationale to evaluate cemiplimab in locally advanced bcc
-
0:52
benefit with cemiplimab in patients with mcscc
-
2:35
patient follow-up after receiving cemiplimab